These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 23935499)

  • 41. Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys.
    Blaney JE; Matro JM; Murphy BR; Whitehead SS
    J Virol; 2005 May; 79(9):5516-28. PubMed ID: 15827166
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2.
    Blaney JE; Hanson CT; Hanley KA; Murphy BR; Whitehead SS
    BMC Infect Dis; 2004 Oct; 4():39. PubMed ID: 15461822
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dengue-2 vaccine: viremia and immune responses in rhesus monkeys.
    Scott RM; Nisalak A; Eckels KH; Tingpalapong M; Harrison VR; Gould DJ; Chapple FE; Russell PK
    Infect Immun; 1980 Jan; 27(1):181-6. PubMed ID: 6766903
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Attenuated D2 16681-PDK53 vaccine: defining humoral and cell-mediated immunity.
    Rabablert J; Yoksan S
    Curr Pharm Des; 2009; 15(11):1203-11. PubMed ID: 19355961
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Introduction of mutations into the non-structural genes or 3' untranslated region of an attenuated dengue virus type 4 vaccine candidate further decreases replication in rhesus monkeys while retaining protective immunity.
    Hanley KA; Manlucu LR; Manipon GG; Hanson CT; Whitehead SS; Murphy BR; Blaney JE
    Vaccine; 2004 Sep; 22(25-26):3440-8. PubMed ID: 15308370
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of a tetravalent chimeric dengue vaccine (DENVax) in Cynomolgus macaques.
    Osorio JE; Brewoo JN; Silengo SJ; Arguello J; Moldovan IR; Tary-Lehmann M; Powell TD; Livengood JA; Kinney RM; Huang CY; Stinchcomb DT
    Am J Trop Med Hyg; 2011 Jun; 84(6):978-87. PubMed ID: 21633037
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development and clinical evaluation of multiple investigational monovalent DENV vaccines to identify components for inclusion in a live attenuated tetravalent DENV vaccine.
    Durbin AP; Kirkpatrick BD; Pierce KK; Schmidt AC; Whitehead SS
    Vaccine; 2011 Sep; 29(42):7242-50. PubMed ID: 21781997
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lack of viraemia and limited antibody response of dengue virus immune rhesus monkeys after vaccination with DEN-2/S-1 vaccine.
    Kraiselburd E; Kessler MJ; Torres-Blasini G
    Trans R Soc Trop Med Hyg; 1984; 78(4):445-8. PubMed ID: 6548325
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.
    Prompetchara E; Ketloy C; Keelapang P; Sittisombut N; Ruxrungtham K
    Asian Pac J Allergy Immunol; 2015 Sep; 33(3):182-8. PubMed ID: 26342114
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mouse models for dengue vaccines and antivirals.
    Plummer EM; Shresta S
    J Immunol Methods; 2014 Aug; 410():34-8. PubMed ID: 24440090
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elaboration of tetravalent antibody responses against dengue viruses using a subunit vaccine comprised of a single consensus dengue envelope sequence.
    Sun J; Li M; Wang Y; Hao P; Jin X
    Vaccine; 2017 Nov; 35(46):6308-6320. PubMed ID: 28987441
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of bivalent and tetravalent dengue vaccine formulations in flavivirus-naïve adults in Mexico.
    Dayan GH; Galán-Herrera JF; Forrat R; Zambrano B; Bouckenooghe A; Harenberg A; Guy B; Lang J
    Hum Vaccin Immunother; 2014; 10(10):2853-63. PubMed ID: 25483647
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of the Type-Specific and Cross-Reactive B-Cell Responses Elicited by a Live-Attenuated Tetravalent Dengue Vaccine.
    Michlmayr D; Andrade P; Nascimento EJM; Parker A; Narvekar P; Dean HJ; Harris E
    J Infect Dis; 2021 Feb; 223(2):247-257. PubMed ID: 32572472
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A heterologous prime-boost strategy for immunization against Dengue virus combining the Tetra DIIIC subunit vaccine candidate with the TV005 live-attenuated tetravalent vaccine.
    Valdés I; Izquierdo A; Cobas K; Thao P; Anh Duc H; Duc Loc H; Dung LT; Lazo L; Suzarte E; Pérez Y; Romero Y; Yaugel M; Marcos E; Guzmán MG; Dat DT; Hien ND; Guillén G; Gil L; Hermida L
    J Gen Virol; 2019 Jun; 100(6):975-984. PubMed ID: 31090533
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human CD4
    Angelo MA; Grifoni A; O'Rourke PH; Sidney J; Paul S; Peters B; de Silva AD; Phillips E; Mallal S; Diehl SA; Kirkpatrick BD; Whitehead SS; Durbin AP; Sette A; Weiskopf D
    J Virol; 2017 Mar; 91(5):. PubMed ID: 27974563
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunogenicity of the CYD tetravalent dengue vaccine using an accelerated schedule: randomised phase II study in US adults.
    Kirstein J; Douglas W; Thakur M; Boaz M; Papa T; Skipetrova A; Plennevaux E
    BMC Infect Dis; 2018 Sep; 18(1):475. PubMed ID: 30241510
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monkeys immunized with intertypic chimeric dengue viruses are protected against wild-type virus challenge.
    Bray M; Men R; Lai CJ
    J Virol; 1996 Jun; 70(6):4162-6. PubMed ID: 8648761
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Using a Virion Assembly-Defective Dengue Virus as a Vaccine Approach.
    Shan C; Xie X; Zou J; Züst R; Zhang B; Ambrose R; Mackenzie J; Fink K; Shi PY
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30111567
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Wild dengue virus types 1, 2 and 3 viremia in rhesus monkeys.
    Freire M; Marchevsky R; Almeida L; Yamamura A; Caride E; Brindeiro P; Motta M; Nogueira R; Kubelka C; Bonaldo M; Galler R
    Mem Inst Oswaldo Cruz; 2007 May; 102(2):203-8. PubMed ID: 17426886
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dengue vaccine: an update on recombinant subunit strategies.
    Martin J; Hermida L
    Acta Virol; 2016 Mar; 60(1):3-14. PubMed ID: 26982462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.